301331 恩威医药
2024/09 - 九个月
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资330-11.76%374352419854
投资性房地产29,075-5.82%30,87333,27035,66738,064
固定资产209,540-5.03%220,638204,314217,927177,401
在建工程35,605303.78%8,81835,68423,84346,745
无形资产137,396-7.19%148,04442,08347,45352,257
商誉100,5530.00%100,553100,553100,553100,553
其他非流动资产45,85610.93%41,33832,53729,46224,197
558,3561.40%550,638448,793455,323440,071

流动资产
货币资金366,01155.01%236,121341,57864,25063,019
应收账款104,09811.82%93,09698,33174,64072,594
存货107,4890.11%107,367104,646110,01278,337
其他流动资产286,940-18.08%350,276412,732164,864194,835
864,5389.87%786,859957,287413,767408,785

流动负债
短期借款0--0000
应付票据0--0000
应付帐款30,387-1.79%30,94136,87633,64145,953
其他流动负债147,637-17.44%178,832190,708165,577188,227
178,024-15.13%209,773227,584199,218234,180
流动资产净值686,51418.96%577,086729,703214,548174,605
资产总额减流动负债1,244,87010.39%1,127,7251,178,496669,871614,676

非流动负债
长期借款200,000--0000
应付债券0--0000
其他非流动负债22,906-6.65%24,53925,49327,62028,160
222,906808.37%24,53925,49327,62028,160

总权益
    实收股本102,89246.70%70,13870,13852,59852,598
    储备项目919,072-11.03%1,033,0481,082,865589,653533,919
股东权益1,021,964-7.36%1,103,1861,153,003642,252586,517
非控股权益0--0000